Literature DB >> 29319177

Characterization of ectopic lymphoid structures in different types of acute renal allograft rejection.

K de Leur1,2, M C Clahsen-van Groningen3, T P P van den Bosch3, G N de Graav1, D A Hesselink1, J N Samsom4, C C Baan1, K Boer1.   

Abstract

We hypothesize that T cells such as interleukin (IL)-21+ B cell lymphoma 6 (BCL6)+ T follicular helper cells can regulate B cell-mediated immunity within the allograft during acute T cell-mediated rejection; this process may feed chronic allograft rejection in the long term. To investigate this mechanism, we determined the presence and activation status of organized T and B cells in so-called ectopic lymphoid structures (ELSs) in different types of acute renal allograft rejection. Biopsies showing the following primary diagnosis were included: acute/active antibody-mediated rejection, C4d+ (a/aABMR), acute T cell-mediated rejection grade I (aTCMRI) and acute T cell-mediated rejection grade II (aTCMRII). Paraffin sections were stained for T cells (CD3 and CD4), B cells (CD20), follicular dendritic cells (FDCs, CD23), activated B cells (CD79A), immunoglobulin (Ig)D, cell proliferation (Ki67) and double immunofluorescent stainings for IL-21 and BCL6 were performed. Infiltrates of T cells were detected in all biopsies. In aTCMRI, B cells formed aggregates surrounded by T cells. In these aggregates, FDCs, IgD and Ki67 were detected, suggesting the presence of ELSs. In contrast, a/aABMR and aTCMRII showed diffuse infiltrates of T and B cells but no FDCs and IgD. IL-21 was present in all biopsies. However, co-localization with BCL6 was observed mainly in aTCMRI biopsies. In conclusion, ELSs with an activated phenotype are found predominantly in aTCMRI where T cells co-localize with B cells. These findings suggest a direct pathway of B cell alloactivation at the graft site during T cell mediated rejection.
© 2018 British Society for Immunology.

Entities:  

Keywords:  B cell; T cell; acute renal allograft rejection; ectopic lymphoid structures; tertiary lymphoid structures

Mesh:

Substances:

Year:  2018        PMID: 29319177      PMCID: PMC5904712          DOI: 10.1111/cei.13099

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

Review 1.  T follicular helper cell differentiation, function, and roles in disease.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection.

Authors:  Hooman Noorchashm; Amy J Reed; Susan Y Rostami; Raha Mozaffari; Ghazal Zekavat; Brigitte Koeberlein; Andrew J Caton; Ali Naji
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

3.  Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.

Authors:  Philip F Halloran; Jessica Chang; Konrad Famulski; Luis G Hidalgo; Israel D R Salazar; Maribel Merino Lopez; Arthur Matas; Michael Picton; Declan de Freitas; Jonathan Bromberg; Daniel Serón; Joana Sellarés; Gunilla Einecke; Jeff Reeve
Journal:  J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 10.121

4.  Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.

Authors:  Alexandre Loupy; Dewi Vernerey; Claire Tinel; Olivier Aubert; Jean-Paul Duong van Huyen; Marion Rabant; Jérôme Verine; Dominique Nochy; Jean-Philippe Empana; Frank Martinez; Denis Glotz; Xavier Jouven; Christophe Legendre; Carmen Lefaucheur
Journal:  J Am Soc Nephrol       Date:  2015-01-02       Impact factor: 10.121

5.  Follicular T helper cells and humoral reactivity in kidney transplant patients.

Authors:  G N de Graav; M Dieterich; D A Hesselink; K Boer; M C Clahsen-van Groningen; R Kraaijeveld; N H R Litjens; R Bouamar; J Vanderlocht; M Tilanus; I Houba; A Boonstra; D L Roelen; F H J Claas; M G H Betjes; W Weimar; C C Baan
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

Review 6.  Effector and regulatory B cells: modulators of CD4+ T cell immunity.

Authors:  Frances E Lund; Troy D Randall
Journal:  Nat Rev Immunol       Date:  2010-03-12       Impact factor: 53.106

7.  B cells help alloreactive T cells differentiate into memory T cells.

Authors:  Y-H Ng; M H Oberbarnscheidt; H C K Chandramoorthy; R Hoffman; G Chalasani
Journal:  Am J Transplant       Date:  2010-09       Impact factor: 8.086

8.  Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties.

Authors:  Mélanie Chesneau; Laure Michel; Emilie Dugast; Alexis Chenouard; Daniel Baron; Annaïck Pallier; Justine Durand; Faouzi Braza; Pierrick Guerif; David-Axel Laplaud; Jean-Paul Soulillou; Magali Giral; Nicolas Degauque; Elise Chiffoleau; Sophie Brouard
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

9.  TLS in Tumors: What Lies Within.

Authors:  Catherine Sautès-Fridman; Wolf Herman Fridman
Journal:  Trends Immunol       Date:  2015-12-17       Impact factor: 16.687

Review 10.  Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity.

Authors:  Kely Campos Navegantes; Rafaelli de Souza Gomes; Priscilla Aparecida Tártari Pereira; Paula Giselle Czaikoski; Carolina Heitmann Mares Azevedo; Marta Chagas Monteiro
Journal:  J Transl Med       Date:  2017-02-15       Impact factor: 5.531

View more
  17 in total

Review 1.  Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection.

Authors:  Kevin Louis; Camila Macedo; Carmen Lefaucheur; Diana Metes
Journal:  Trends Mol Med       Date:  2022-01-29       Impact factor: 11.951

Review 2.  Role of T follicular helper and T follicular regulatory cells in antibody-mediated rejection: new therapeutic targets?

Authors:  Hengcheng Zhang; Peter T Sage
Journal:  Curr Opin Organ Transplant       Date:  2022-08-09       Impact factor: 2.269

Review 3.  How Many Cell Types Are in the Kidney and What Do They Do?

Authors:  Michael S Balzer; Tibor Rohacs; Katalin Susztak
Journal:  Annu Rev Physiol       Date:  2021-11-29       Impact factor: 22.163

Review 4.  Targeting T Follicular Helper Cells to Control Humoral Allogeneic Immunity.

Authors:  Kevin Louis; Camila Macedo; Diana Metes
Journal:  Transplantation       Date:  2021-11-01       Impact factor: 5.385

5.  The Effects of an IL-21 Receptor Antagonist on the Alloimmune Response in a Humanized Mouse Skin Transplant Model.

Authors:  Kitty de Leur; Franka Luk; Thierry P P van den Bosch; Marjolein Dieterich; Luc J W van der Laan; Rudi W Hendriks; Marian C Clahsen-van Groningen; Fadi Issa; Carla C Baan; Martin J Hoogduijn
Journal:  Transplantation       Date:  2019-10       Impact factor: 5.385

6.  Response: Commentary: Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation.

Authors:  Carla C Baan; Gretchen N de Graav; Willem Weimar; Dennis A Hesselink
Journal:  Front Immunol       Date:  2018-03-08       Impact factor: 7.561

Review 7.  T Cells That Help B Cells in Chronically Inflamed Tissues.

Authors:  Deepak A Rao
Journal:  Front Immunol       Date:  2018-08-23       Impact factor: 7.561

8.  Pre-transplant donor-reactive IL-21 producing T cells as a tool to identify an increased risk for acute rejection.

Authors:  Aleixandra Mendoza Rojas; Teun van Gelder; Ronella de Kuiper; Derek Reijerkerk; Marian C Clahsen-van Groningen; Dennis A Hesselink; Carla C Baan; Nicole M van Besouw
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

Review 9.  Plasma cell biology: Foundations for targeted therapeutic development in transplantation.

Authors:  Amy P Rossi; Rita R Alloway; David Hildeman; E Steve Woodle
Journal:  Immunol Rev       Date:  2021-07-12       Impact factor: 10.983

10.  Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients.

Authors:  Qian Niu; Aleixandra Mendoza Rojas; Marjolein Dieterich; Dave L Roelen; Marian C Clahsen-van Groningen; Lanlan Wang; Teun van Gelder; Dennis A Hesselink; Nicole M van Besouw; Carla C Baan
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.